PE20151426A1 - Solucion para preservar conductos vasculares - Google Patents

Solucion para preservar conductos vasculares

Info

Publication number
PE20151426A1
PE20151426A1 PE2015001230A PE2015001230A PE20151426A1 PE 20151426 A1 PE20151426 A1 PE 20151426A1 PE 2015001230 A PE2015001230 A PE 2015001230A PE 2015001230 A PE2015001230 A PE 2015001230A PE 20151426 A1 PE20151426 A1 PE 20151426A1
Authority
PE
Peru
Prior art keywords
solution
less
solution includes
stored
preserve
Prior art date
Application number
PE2015001230A
Other languages
English (en)
Inventor
Mahendra Suryan
Satish Menon
Original Assignee
Somahlution Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51022088&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20151426(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Somahlution Llc filed Critical Somahlution Llc
Publication of PE20151426A1 publication Critical patent/PE20151426A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0236Mechanical aspects
    • A01N1/0242Apparatuses, i.e. devices used in the process of preservation of living parts, such as pumps, refrigeration devices or any other devices featuring moving parts and/or temperature controlling components

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Formulaciones de preservacion de organos y tejidos con una estabilidad de almacenamiento mejorada se proporcionan mediante la separacion de la formulacion en una primera solucion que tiene un pH de al menos 7 y una segunda solucion que tiene un pH de menos de 7. La primera solucion incluye componentes con estabilidad mejorada cuando se almacena a un pH de 7,0 o superior, y la segunda solucion incluye componentes con estabilidad mejorada cuando se almacena a un pH inferior a 7,0. La primera solucion incluye agua, una solucion salina balanceada, un azucar, y L - arginina a un pH de al menos 7,0. La segunda solucion incluye agua, acido ascorbico, y glutation reducido a un pH de menos de 7,0 y preferiblemente de pH 6,9 a aproximadamente pH 2,8. Durante el uso, la primera y segunda soluciones se mezclan para formar una formulacion final que se puede utilizar a un pH fisiologico para preservar la funcion del tejido u organo
PE2015001230A 2012-12-31 2013-12-27 Solucion para preservar conductos vasculares PE20151426A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261848350P 2012-12-31 2012-12-31
US201261848349P 2012-12-31 2012-12-31

Publications (1)

Publication Number Publication Date
PE20151426A1 true PE20151426A1 (es) 2015-09-18

Family

ID=51022088

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001230A PE20151426A1 (es) 2012-12-31 2013-12-27 Solucion para preservar conductos vasculares

Country Status (20)

Country Link
US (2) US20150313209A1 (es)
EP (2) EP2938187B1 (es)
JP (2) JP2016511227A (es)
KR (2) KR20150103069A (es)
CN (2) CN104981151A (es)
AR (2) AR095965A1 (es)
AU (1) AU2013370268A1 (es)
BR (2) BR112015015092A2 (es)
CA (2) CA2896739A1 (es)
CL (1) CL2015001865A1 (es)
CR (2) CR20150309A (es)
DK (2) DK2938186T3 (es)
EA (2) EA201591247A1 (es)
ES (2) ES2724238T3 (es)
HK (2) HK1214924A1 (es)
MX (2) MX2015008528A (es)
PE (1) PE20151426A1 (es)
SG (2) SG11201504785YA (es)
WO (2) WO2014106083A1 (es)
ZA (2) ZA201504103B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201691066A1 (ru) * 2013-11-22 2016-09-30 СОМАЛЮШН, ЭлЭлСи Растворы для повышения стабильности и срок годности раствора для консервирования органов и тканей
US20190045776A1 (en) * 2015-06-09 2019-02-14 President And Fellows Of Harvard College Long term storage and preservation of platelets
BR112017026671A2 (pt) * 2015-06-09 2018-08-14 Harvard College composições e métodos para a preservação de tecidos em temperatura ambiente ou subnormotérmica
WO2017075289A1 (en) 2015-10-27 2017-05-04 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN106417254A (zh) * 2016-09-30 2017-02-22 广州赛莱拉干细胞科技股份有限公司 一种牙齿标本保存液及其应用以及牙齿标本保存方法
EP3527077A4 (en) * 2016-11-25 2020-05-06 Terumo Kabushiki Kaisha PRESERVATION SOLUTION FOR LIVING CELLS OR COMPOSITION WITH LIVING CELLS
EP3920846A4 (en) * 2019-02-06 2022-11-09 The Board and Trustees of the Leland Stanford Junior University BIOLOGICALLY MODIFIED VASCULAR GRAFTS FOR IMPROVED BYPASS SURGERY RESULTS
US20230390172A1 (en) * 2022-06-02 2023-12-07 Dermaforce Holdings, LLC Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837021A (en) * 1986-12-31 1989-06-06 Laboratoires P.O.S. Two part tissue irrigating solution
US5066578A (en) * 1989-12-21 1991-11-19 The Regents Of The University Of California Long-term preservation of organs for transplantation
WO1992008349A1 (en) * 1990-11-07 1992-05-29 Baxter International Inc. Blood platelet storage medium
JP3623294B2 (ja) * 1995-11-28 2005-02-23 株式会社新素材総合研究所 電解質液が収容された医療用容器及びその製造方法
US6153582A (en) * 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US7611830B2 (en) * 2000-04-10 2009-11-03 The United States Of America As Represented By The Department Of Veteran's Affairs Device to lavage a blood vessel
US6569615B1 (en) * 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
US20060093765A1 (en) 2004-10-29 2006-05-04 Sealed Air Corporation (Us) Multi-compartment pouch having a frangible seal
CA2664341C (en) * 2006-10-05 2018-11-06 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
CN101790306A (zh) 2007-02-17 2010-07-28 哈佛学院董事会 用于进行组织保存的组合物以及方法
US8608922B2 (en) * 2008-11-07 2013-12-17 The University Of Connecticut Biosensor for continuous monitoring of metabolites and proteins and methods of manufacture thereof
JP4901984B2 (ja) 2010-07-30 2012-03-21 株式会社東芝 情報処理装置及びその制御方法

Also Published As

Publication number Publication date
SG11201504812SA (en) 2015-07-30
CA2896739A1 (en) 2014-07-03
CR20150310A (es) 2015-09-24
EP2938186A4 (en) 2016-08-10
WO2014106091A1 (en) 2014-07-03
KR20150103067A (ko) 2015-09-09
EP2938187A4 (en) 2016-08-10
AR095964A1 (es) 2015-11-25
CN104981151A (zh) 2015-10-14
MX2015008529A (es) 2016-02-10
EP2938186A1 (en) 2015-11-04
KR20150103069A (ko) 2015-09-09
BR112015015092A2 (pt) 2017-07-11
WO2014106083A1 (en) 2014-07-03
CL2015001865A1 (es) 2015-11-13
EP2938187A1 (en) 2015-11-04
JP2016511227A (ja) 2016-04-14
CN104981152A (zh) 2015-10-14
ES2648523T3 (es) 2018-01-03
ES2724238T3 (es) 2019-09-09
CR20150309A (es) 2015-09-24
MX2015008528A (es) 2016-02-10
US20150342175A1 (en) 2015-12-03
CA2896741A1 (en) 2014-07-03
US20150313209A1 (en) 2015-11-05
SG11201504785YA (en) 2015-07-30
DK2938187T3 (en) 2017-12-04
ZA201504284B (en) 2024-02-28
JP2016505608A (ja) 2016-02-25
HK1214924A1 (zh) 2016-08-12
EP2938187B1 (en) 2017-09-27
EA201591247A1 (ru) 2016-02-29
HK1214923A1 (zh) 2016-08-12
AR095965A1 (es) 2015-11-25
EP2938186B1 (en) 2019-02-06
BR112015015090A2 (pt) 2017-07-11
AU2013370268A1 (en) 2015-06-18
EA201591246A1 (ru) 2016-02-29
DK2938186T3 (da) 2019-05-13
ZA201504103B (en) 2024-02-28

Similar Documents

Publication Publication Date Title
PE20151426A1 (es) Solucion para preservar conductos vasculares
MX352823B (es) Formulaciones de proteinas que contienen aminoacidos.
PH12015502542A1 (en) Stabilized pemetrexed formulation
MX352745B (es) Soluciones estabilizadas de acido hipohaloso.
WO2014172631A3 (en) Expression of biologically active proteins in a bacterial cell-free synthesis system using cell extracts with elevated levels of exogenous chaperones
AR088381A1 (es) Formulaciones de etanercept estabilizadas con meglumina
DOP2012000261A (es) Formulaciones de insulina de accion prolongada
UY36542A (es) Formulaciones farmacéuticas para anticuerpos anti-tnf-alfa
CR20160188A (es) Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido
CO6620001A2 (es) Composiciones cosmeticas
BR112016013322A2 (pt) Métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
MY178249A (en) Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same
WO2015171460A3 (en) Formulations of cyclophosphamide liquid concentrate
BR112017026666A2 (pt) armazenagem de longo prazo e conservação de plaquetas
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
CO2018012502A2 (es) Formulaciones y métodos para el tratamiento de organismos fotosintéticos y la mejora de las calidades y cantidades de rendimientos con formulaciones de compuestos de glicano
PH12016500572A1 (en) Solid dialysis a agent containing alkali metal diacetate, and two-part type low-acetate dialysis agent using same
AR086437A1 (es) Preparado de huevo con propiedades regeneradoras, analgesicas y/o anti-inflamatorias
BR112018004244A2 (pt) formulações sólidas de pirofosfato férrico solúvel, kits e seus métodos de uso
TH172594A (th) วิธีแก้ปัญหาสำหรับการเพิ่มเสถียรภาพและอายุการเก็บบนชั้นของสารละลาย การเก็บถนอมเนื้อเยื่อและอวัยวะ
UA92408U (ru) Крем для применения при синдроме диабетической стопы у больных сахарным диабетом
Syrkin et al. Results of a Proper Strategy of the Use of Donor Heart Transplant for Urgent Transplantation to a Status 1A UNOS Recipient
AR089518A1 (es) Costra artificial porosa semipermeable
TH91781B (th) อนุพันธ์ของ n3-ซับสทิทิวเทด-n1-ซัลโฟนิล-5-ฟลูออโรพิริมิดิโนน

Legal Events

Date Code Title Description
FD Application declared void or lapsed